CVE-2019-10964

Summary

Medtronic MiniMed Insulin Pumps

are designed to communicate using a wireless RF with other devices, such as blood glucose meters, glucose sensor transmitters, and CareLink USB devices. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with adjacent access to one of the affected insulin pump models can inject, replay, modify, and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Affected Software

VendorProductVersion RangeStatus
MedtronicMiniMed 508 pumpAll versionsaffected
MedtronicMiniMed Paradigm 511 pumpAll versionsaffected
MedtronicMiniMed Paradigm 512/712 pumpsAll versionsaffected
MedtronicMiniMed Paradigm 712E pumpAll versionsaffected
MedtronicMiniMed Paradigm 515/715 pumpsAll versionsaffected
MedtronicMiniMed Paradigm 522/722 pumpsAll versionsaffected
MedtronicMiniMed Paradigm 522K/722K pumpsAll versionsaffected
MedtronicMiniMed Paradigm 523/723 pumps0 <= Software Versions 2.4Aaffected
MedtronicMiniMed Paradigm 523K/723K pumps0 <= Software Versions 2.4Aaffected
MedtronicMiniMed Paradigm Veo 554/754 pumps0 <= Software Versions 2.6Aaffected
MedtronicMiniMed Paradigm Veo 554CM/754CM pumps0 <= Software Versions 2.7Aaffected

Weaknesses

  • CWE-284: CWE-284

Workarounds

Medtronic recommends U.S. patients who are currently using the affected products talk to their healthcare provider about changing to a newer model insulin pump with increased cybersecurity protection. Patients outside the U.S. will receive a notification letter with instructions based on the country where they live.

Medtronic recommends all patients take the cybersecurity precautions indicated below.

CYBERSECURITY PRECAUTIONS RECOMMENDED FOR ALL PATIENTS:

  • Maintain tight physical control of the pump and devices connected to the pump
  • Do not share pump serial number
  • Be attentive to pump notifications, alarms, and alerts
  • Immediately cancel any unintended boluses (a single dose of insulin administered all at once)
  • Do not connect to any third-party devices or use any software not authorized by Medtronic
  • Disconnect CareLink USB devices from computers when not being used to download data from the pump
  • Monitor blood glucose levels closely and act as appropriate
  • Get medical help immediately when experiencing symptoms of severe hypoglycemia or diabetic ketoacidosis, or suspect an insulin pump settings, or insulin delivery have changed unexpectedly

Medtronic has released additional patient-focused information, at the following location:

https://www.medtronic.com/security

ADP Enrichment

CVE Program Container

Additional References

References